Related Experiment Video
Updated: Jun 7, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis
Ie-Ming Shih1, Li Chen, Chen C Wang
1Division of Gynecologic Pathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. ishih@jhmi.edu
Objective:
The purpose of this study was to analyze DNA methylation profiles among different types of ovarian serous neoplasm, which is a task that has not been performed.
Study Design:
The Illumina beads array (Illumina Inc, San Diego, CA) was used to profile DNA methylation in enriched tumor cells that had been isolated from 75 benign and malignant serous tumor tissues and 6 tumor-associated stromal cell cultures.
Results:
We found significantly fewer hypermethylated genes in high-grade serous carcinomas than in low-grade serous carcinoma and borderline tumors, which in turn had fewer hypermethylated genes than serous cystadenoma. Unsupervised analysis identified that serous cystadenoma, serous borderline tumor, and low-grade serous carcinomas tightly clustered together and were clearly different from high-grade serous carcinomas. We also performed supervised analysis to identify differentially methylated genes that may contribute to group separation.
Conclusion:
The findings support the view that low-grade and high-grade serous carcinomas are distinctly different with low-grade, but not high-grade, serous carcinomas that are related to serous borderline tumor and cystadenoma.
Insights
DNA methylation profiles differ across ovarian serous neoplasms. High-grade serous carcinomas show fewer hypermethylated genes than low-grade types, suggesting distinct biological pathways.
Area of Science:
- Oncology
- Epigenetics
- Gynecologic Pathology
Background:
- Ovarian serous neoplasms represent a spectrum of tumors with varying grades of malignancy.
- Understanding the molecular underpinnings, particularly epigenetic alterations like DNA methylation, is crucial for accurate classification and diagnosis.
Purpose of the Study:
- To investigate and compare DNA methylation profiles across various types of ovarian serous neoplasms.
- To identify potential epigenetic distinctions between benign, borderline, and malignant serous tumors.
Main Methods:
- Utilized Illumina bead array technology for DNA methylation profiling.
- Analyzed DNA methylation in enriched tumor cells from 75 benign and malignant serous tumor tissues.
- Included 6 tumor-associated stromal cell cultures in the analysis.
Main Results:
- High-grade serous carcinomas exhibited significantly fewer hypermethylated genes compared to low-grade serous carcinoma and borderline tumors.
- Serous cystadenomas had the highest number of hypermethylated genes.
- Unsupervised analysis revealed distinct clustering: serous cystadenoma, serous borderline tumor, and low-grade serous carcinomas grouped together, separate from high-grade serous carcinomas.
Conclusions:
- Low-grade and high-grade serous carcinomas represent distinct entities at the molecular level.
- Low-grade serous carcinomas share epigenetic similarities with serous borderline tumors and cystadenomas, suggesting a potential developmental or etiological link.
- High-grade serous carcinomas appear epigenetically divergent from lower-grade counterparts and benign/borderline lesions.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Oogenesis

